Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
06/1999
06/16/1999EP0922030A1 Arylsulfonylamino hydroxamic acid derivatives
06/16/1999EP0827507B1 Protease inhibiting succinic acid derivatives
06/16/1999CN1219926A Phenylthanolaminotetralin carboxamide derivatives
06/15/1999US5912387 Amine heat stable salt neutralization having reduced solids
06/15/1999US5912360 Dioxolane intermediates
06/15/1999US5912350 Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands
06/15/1999US5911970 Antitumor agents and anticarcinogenic agents
06/10/1999WO1999028310A1 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
06/10/1999WO1999027937A2 Method for inhibiting cytokine production by cells
06/10/1999CA2312023A1 Method for inhibiting cytokine production by cells
06/09/1999EP0921117A2 Acylguanidines
06/09/1999EP0921116A1 N-(4-carbamimido-phenyl)-glycine amide derivatives
06/09/1999EP0920456A1 Phosgenated oxime resins and their preparation
06/09/1999EP0920414A1 Matrix metalloproteinase inhibitors
06/09/1999EP0920312A1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
06/09/1999EP0920306A2 Chemokine receptor antagonists and methods of use therefor
06/09/1999CN1219170A Substituted 1,2,3,4-tetrahydronaphthalene derivatives
06/09/1999CN1219130A Composition comprising a nitrone compound for use in treating ocular inflammation
06/08/1999US5910549 Reacting radically transferrable atoms or groups with a transition metal or transition metal compound and a stable nitroxide radical; long half-life radical initiators of addition polymerization for controlling polydispersity
06/08/1999US5910499 Leukotriene production inhibiting action and antihistaminic action; oral administration
06/08/1999US5910496 Synergistic mixture comprising at least one systemic, contact and/or soil fungicides and at least one acrylic acid morpholide derivatives
06/08/1999CA2089972C Sulfonamidocarboxamides
06/04/1999CA2255180A1 N-(4-carbamimido-phenyl)-phenylglycinamid derivatives
06/03/1999WO1999026918A1 Biphenylamidine derivatives
06/03/1999WO1999026616A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
06/03/1999WO1999026584A2 Inhibitors of gap junction communication
06/03/1999WO1999010312B1 N-alkanoylphenylalanine derivatives
06/03/1999WO1999005096A3 Urokinase inhibitors
06/03/1999WO1999002502A3 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
06/03/1999CA2310331A1 Biphenylamidine derivatives
06/02/1999EP0919550A1 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
06/02/1999EP0919542A2 Phthalic acid diamide derivatives, agricultural and horticultural insecticides, and a method for application of the insecticides
06/02/1999EP0918761A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
06/02/1999EP0918514A1 Triaryl methane compounds for sickle cell disease
06/02/1999EP0748310B1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
06/02/1999EP0667854B1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences
06/02/1999CN1218460A Substituted 4-hydroxy-phenylalcanoic acid derivatives with activity to ppar-'gamma'
06/01/1999US5908863 Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism
06/01/1999US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents
05/1999
05/27/1999WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
05/26/1999EP0918296A1 Method of virtual retrieval of analogs of lead compounds by constituting potential libraries
05/26/1999EP0917531A1 New piperazine derivatives and oxydation dyes
05/26/1999EP0917465A1 Antimalarial and anti-babesiosis agents and pharmaceutical compositions containing same
05/26/1999EP0917464A1 Use of amines to produce drugs for preventing tumour cell proliferation
05/26/1999EP0917462A1 Cell adhesion inhibitors
05/26/1999EP0686625B1 Anthranilic acid derivative
05/25/1999US5907039 Amino alcohol derivative and method for preparing the same
05/25/1999US5906988 Methods of treatment using ranolazine and related piperazine derivatives
05/25/1999CA1340561C Process for preparing ciprofloxacine
05/20/1999WO1999024460A2 Dipeptide nitriles
05/20/1999WO1999024395A1 Compounds which inhibit tryptase activity
05/20/1999WO1999024393A1 Process to produce oxazolidinones
05/20/1999CA2634657A1 Process to produce oxazolidinones
05/20/1999CA2304100A1 Process to produce oxazolidinones
05/19/1999EP0916675A2 Process for preparing sildenafil
05/19/1999EP0916652A1 N-Aryl 2-hydroxy alkylamides
05/19/1999EP0915860A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands
05/19/1999EP0915859A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
05/19/1999EP0915855A1 Novel compounds with analgesic effect
05/19/1999EP0915841A1 Anilinopeptide derivatives
05/19/1999EP0915823A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
05/19/1999EP0690851B1 Guanidine derivatives useful in therapy
05/19/1999CN1216977A Alkoxy acetic acid derivatives
05/18/1999US5905080 Central nervous system, psychological, eating disorders; cognition activators, parkinson*s disease
05/18/1999US5904818 Process for the regeneration of an aqueous process liquid of the amine-oxide process
05/18/1999CA2040884C Process for the preparation of 1-(2,3,4-trimethoxybenzyl) piperazine by reductive amination
05/18/1999CA1340543C Pharmaceutically active compounds
05/14/1999WO1999023587A2 Method of virtual retrieval of analogs of lead compounds
05/14/1999WO1999023073A1 Biphenyl derivatives as pharmaceuticals
05/14/1999WO1999023072A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
05/14/1999WO1999023063A1 Substituted anilides
05/14/1999WO1999001423A8 Glucagon antagonists/inverse agonists
05/14/1999CA2681877A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
05/14/1999CA2308151A1 Biphenyl derivatives as pharmaceuticals
05/14/1999CA2306822A1 Method of virtual retrieval of analogs of lead compounds
05/12/1999EP0915086A1 Phenylsulfonamide derivatives
05/12/1999EP0914605A1 Molecular model for vla-4 inhibitors
05/12/1999EP0914319A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
05/12/1999CN1216526A 3,4-disubstituted phenylethanolaminotetra lincarboxamide derivatives
05/11/1999US5902883 Cyanobutylation of ammonia, alkylamines and hydrazine with 3-pentenenitrile, 4-pentenenitrile or mixtures thereof
05/06/1999WO1999021850A1 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d4 receptor subtype ligands
05/06/1999WO1999021846A1 Cyclopentene derivatives useful as antagonists of the motilin receptor
05/06/1999WO1999021422A1 Treatment of schizophrenia with ampakines and neuroleptics
05/06/1999WO1999015493A8 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
05/06/1999WO1998055448A3 Fluoroalkene carboxylic acid derivatives, method for producing said derivatives, and insecticidal agents containing the same
05/06/1999EP0912534A1 Muscarinic antagonists
05/06/1999EP0912513A1 Fibrinogen receptor antagonist prodrugs
05/06/1999EP0912499A1 Pesticides
05/06/1999EP0912182A1 Fibrinogen receptor antagonist prodrugs
05/06/1999EP0912175A1 Fibrinogen receptor antagonists
05/06/1999EP0912170A1 Hiv protease inhibitors useful for the treatment of aids
05/06/1999EP0750607B1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity
05/06/1999CA2308057A1 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d4 receptor subtype ligands
05/06/1999CA2307661A1 Cyclopentene derivatives useful as antagonists of the motilin receptor
05/06/1999CA2306817A1 Treatment of schizophrenia with ampakines and neuroleptics
05/05/1999CN1215719A Preparation of amines
05/05/1999CN1043228C Process for producing halogenophennoxyfatty acid derivs. by selective halogenation and halogenophenoxyfatty acid derivs.
05/04/1999US5900485 Methods for the manufacture of neofazodone
05/04/1999US5900415 Dietetic and cardiovascular disorders
05/04/1999CA2022783C Vicinal di (hetero) alkylene organometalates and processes for the production of amines therewith